StockData
Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc. (VICP) stock

VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)

Close on Oct 19, 2026Market cap $13.73MP/E –Yield –

Vicapsys Life Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Vicapsys Life Sciences's total debt was $12.55K at Jun 30, 2024. For fiscal 2023 it was $18.71K.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$18.71K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024$12.55K-76.9%
Q1 FY2024Mar 31, 2024$12.55K–
Q4 FY2023Dec 31, 2023$18.71K–
Q3 FY2023Sep 30, 2023$36.79K–
Q2 FY2023Jun 30, 2023$54.23K–

More Vicapsys Life Sciences figures

See a number that looks wrong?